These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 10087001

  • 1. Central administration of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)-NH2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats.
    Kapusta DR, Chang JK, Kenigs VA.
    J Pharmacol Exp Ther; 1999 Apr; 289(1):173-80. PubMed ID: 10087001
    [Abstract] [Full Text] [Related]

  • 2. Functional selectivity of nociceptin/orphanin FQ peptide receptor partial agonists on cardiovascular and renal function.
    Kapusta DR, Burmeister MA, Calo' G, Guerrini R, Gottlieb HB, Kenigs VA.
    J Pharmacol Exp Ther; 2005 Aug; 314(2):643-51. PubMed ID: 15855356
    [Abstract] [Full Text] [Related]

  • 3. Centrally administered nociceptin/orphanin FQ (N/OFQ) evokes bradycardia, hypotension, and diuresis in mice via activation of central N/OFQ peptide receptors.
    Burmeister MA, Kapusta DR.
    J Pharmacol Exp Ther; 2007 Jul; 322(1):324-31. PubMed ID: 17452419
    [Abstract] [Full Text] [Related]

  • 4. [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as an agonist of the orphanin FQ/nociceptin receptor in vivo.
    Grisel JE, Farrier DE, Wilson SG, Mogil JS.
    Eur J Pharmacol; 1998 Sep 11; 357(1):R1-3. PubMed ID: 9788779
    [Abstract] [Full Text] [Related]

  • 5. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
    Carrà G, Rizzi A, Guerrini R, Barnes TA, McDonald J, Hebbes CP, Mela F, Kenigs VA, Marzola G, Rizzi D, Gavioli E, Zucchini S, Regoli D, Morari M, Salvadori S, Rowbotham DJ, Lambert DG, Kapusta DR, Calo' G.
    J Pharmacol Exp Ther; 2005 Mar 11; 312(3):1114-23. PubMed ID: 15509719
    [Abstract] [Full Text] [Related]

  • 6. [Phe1psi(CH2-NH)Gly2]-nociceptin-(1-13)NH2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord.
    Xu IS, Wiesenfeld-Hallin Z, Xu XJ.
    Neurosci Lett; 1998 Jun 19; 249(2-3):127-30. PubMed ID: 9682833
    [Abstract] [Full Text] [Related]

  • 7. Tonic nociceptinergic inputs to neurons in the hypothalamic paraventricular nucleus contribute to sympathetic vasomotor tone and water and electrolyte homeostasis in conscious rats.
    Krowicki ZK, Kapusta DR.
    J Pharmacol Exp Ther; 2006 Apr 19; 317(1):446-53. PubMed ID: 16407463
    [Abstract] [Full Text] [Related]

  • 8. Central G-alpha subunit protein-mediated control of cardiovascular function, urine output, and vasopressin secretion in conscious Sprague-Dawley rats.
    Wainford RD, Kurtz K, Kapusta DR.
    Am J Physiol Regul Integr Comp Physiol; 2008 Aug 19; 295(2):R535-42. PubMed ID: 18525017
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular and renal responses produced by central orphanin FQ/nociceptin occur independent of renal nerves.
    Kapusta DR, Kenigs VA.
    Am J Physiol; 1999 Oct 19; 277(4):R987-95. PubMed ID: 10516236
    [Abstract] [Full Text] [Related]

  • 10. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
    Leggett JD, Harbuz MS, Jessop DS, Fulford AJ.
    Neuroscience; 2006 Sep 15; 141(4):2051-7. PubMed ID: 16784820
    [Abstract] [Full Text] [Related]

  • 11. Nociceptin/orphanin FQ (N/OFQ)-evoked bradycardia, hypotension, and diuresis are absent in N/OFQ peptide (NOP) receptor knockout mice.
    Burmeister MA, Ansonoff MA, Pintar JE, Kapusta DR.
    J Pharmacol Exp Ther; 2008 Sep 15; 326(3):897-904. PubMed ID: 18539652
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor.
    Rizzi A, Spagnolo B, Wainford RD, Fischetti C, Guerrini R, Marzola G, Baldisserotto A, Salvadori S, Regoli D, Kapusta DR, Calo G.
    Peptides; 2007 Jun 15; 28(6):1240-51. PubMed ID: 17532097
    [Abstract] [Full Text] [Related]

  • 13. Chronic high-NaCl intake prolongs the cardiorenal responses to central N/OFQ and produces regional changes in the endogenous brain NOP receptor system.
    Wainford RD, Kapusta DR.
    Am J Physiol Regul Integr Comp Physiol; 2009 Feb 15; 296(2):R280-8. PubMed ID: 18987291
    [Abstract] [Full Text] [Related]

  • 14. Pharmacodynamic characterization of ZP120 (Ac-RYYRWKKKKKKK-NH2), a novel, functionally selective nociceptin/orphanin FQ peptide receptor partial agonist with sodium-potassium-sparing aquaretic activity.
    Kapusta DR, Thorkildsen C, Kenigs VA, Meier E, Vinge MM, Quist C, Petersen JS.
    J Pharmacol Exp Ther; 2005 Aug 15; 314(2):652-60. PubMed ID: 15855355
    [Abstract] [Full Text] [Related]

  • 15. [Phe1psi(CH2-NH)Gly2]nociceptin-(1 - 13)-NH2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray.
    Chiou LC.
    Br J Pharmacol; 1999 Sep 15; 128(1):103-7. PubMed ID: 10498840
    [Abstract] [Full Text] [Related]

  • 16. Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor.
    Peng YL, Chang M, Dong SL, Li W, Han RW, Fu GX, Chen Q, Wang R.
    Regul Pept; 2006 May 15; 134(2-3):75-81. PubMed ID: 16516988
    [Abstract] [Full Text] [Related]

  • 17. Role of nociceptin/orphanin FQ and the pseudopeptide [Phe1Psi(CH2NH)Gly2]-nociceptin(1-13)-NH2 and their interaction with classic opioids in the modulation of thermonociception in the land snail Helix aspersa.
    Miller-Pérez C, Sánchez-Islas E, Pellicer F, Rodríguez-Manzo G, Cruz SL, León-Olea M.
    Eur J Pharmacol; 2008 Feb 26; 581(1-2):77-85. PubMed ID: 18096155
    [Abstract] [Full Text] [Related]

  • 18. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ).
    Kapusta DR, Sezen SF, Chang JK, Lippton H, Kenigs VA.
    Life Sci; 1997 Feb 26; 60(1):PL15-21. PubMed ID: 8995537
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of cardiovascular activity following microinjection of novel opioid-like neuropeptide nociceptin (orphanin FQ) into the rat rostral ventrolateral medulla.
    Chu X, Xu N, Li P, Mao L, Wang JQ.
    Brain Res; 1999 May 22; 829(1-2):134-42. PubMed ID: 10350539
    [Abstract] [Full Text] [Related]

  • 20. Nociceptin/orphanin FQ and [Phe(1)psi(CH2-NH)Gly2]nociceptin(1-13)NH2 modulates the activity of hypothalamic paraventricular nucleus neurons in vitro.
    Shirasaka T, Miyahara S, Takasaki M, Kannan H.
    Brain Res; 2001 Jan 26; 890(1):147-53. PubMed ID: 11164777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.